Is National Immunotherapy Cancer Research Foundation Inc Legit?
Quick charity verification for National Immunotherapy Cancer Research Foundation Inc (EIN: 223067246)
Verdict: National Immunotherapy Cancer Research Foundation Inc shows mixed signals
45/100Mission Score
$526KRevenue
$1.2MAssets
4Red Flags
2Strengths
Red Flags
In 2023, only $15,146 (approx. 10% of total expenses) was spent on programs, despite $1,051,896 in assets.
Significant fluctuations in revenue, from $330,414 in 2019 to $4,423 in 2022, raise questions about funding stability and strategy.
A high percentage of expenses consistently allocated to administrative and fundraising activities rather than direct program services.
Lack of detailed information regarding executive compensation and specific program outcomes.
Strengths
The organization maintains a healthy asset base, with $1,051,896 in 2023, indicating financial stability.
Consistent filing of financial documents, demonstrating adherence to reporting requirements.
AI Transparency Report
National Immunotherapy Cancer Research Foundation Inc is a medical research nonprofit based in Flemington, New Jersey, with reported revenue of $526K and assets of $1.2M. Our AI analysis assigns a Mission Score of 45/100 (Fair). Approximately 15% of spending goes to programs, 50% to administration, and 35% to fundraising. Executive compensation cannot be assessed as it is not disclosed in the provided data, which is a significant transparency concern for an organization with substantial assets. Revenue has declined -34% across 14 filing periods.